DEUTSCHE BANK AG\

Holdings History for Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KROS)

Symbol: KROS on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$3,975,921	195,281	+172,022	+740%	$20.36	Q4 2025
30 Sep 2025	0%	-0%	$367,957	23,259	-188,378	-89%	$15.82	Q3 2025
30 Jun 2025	0%	+0%	$2,825,354	211,637	+188,675	+822%	$13.35	Q2 2025
31 Mar 2025	0%	-0%	$233,983	22,962	-3,995		$10.19	Q1 2025
31 Dec 2024	0%	+0%	$426,729	26,957	+8,447		$15.83	Q4 2024
30 Sep 2024	0%	-0%	$1,074,875	18,510	-105,603		$58.07	Q3 2024
30 Jun 2024	0%	+0%	$5,671,965	124,113	+41		$45.70	Q2 2024
31 Mar 2024	0%	-0.01%	$8,213,566	124,072	-234,204		$66.20	Q1 2024
31 Dec 2023	0.01%	+0.01%	$14,245,054	358,276	+345,704	+2750%	$39.76	Q4 2023
30 Sep 2023	0%	-0%	$400,795	12,572	-70,319	-85%	$31.88	Q3 2023
30 Jun 2023	0%	-0%	$3,330,560	82,891	-4,505	-5.2%	$40.18	Q2 2023
31 Mar 2023	0%	+0%	$3,731,809	87,396	+75,946	+663%	$42.70	Q1 2023
31 Dec 2022	0%	+0%	$549,829	11,450	+3,406	+42%	$48.02	Q4 2022
30 Sep 2022	0%	-0%	$303,000	8,044	-2,231	-22%	$37.67	Q3 2022
30 Jun 2022	0%	+0%	$285,000	10,275	+135	+1.3%	$27.74	Q2 2022
31 Mar 2022	0%	-0%	$552,000	10,140	-1,006	-9%	$54.44	Q1 2022
31 Dec 2021	0%	+0%	$652,000	11,146	+369	+3.4%	$58.50	Q4 2021
30 Sep 2021	0%	-0%	$427,000	10,777	-287	-2.6%	$39.62	Q3 2021
30 Jun 2021	0%	+0%	$469,000	11,064	+1,412	+15%	$42.39	Q2 2021
31 Mar 2021	0%	-0%	$593,000	9,652	-792	-7.6%	$61.44	Q1 2021
31 Dec 2020	0%	+0%	$736,000	10,444	+6,592	+171%	$70.47	Q4 2020
30 Sep 2020	0%	+0%	$149,000	3,852	+336	+9.6%	$38.68	Q3 2020
30 Jun 2020	0%	+0%	$132,000	3,516	+3,516	NEW	$37.54	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.